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OBJECTIVE — To measure with ultrasound the increased erythrocyte aggregation (EA) ki-
netics and adhesion energy between erythrocytes in patients with type 2 diabetes and poor
metabolic control.
RESEARCH DESIGN AND METHODS — Blood samples were analyzed in a Couette
rheometerat32MHzfollowingshearratereductionsfrom500s
1toresidualshearsof0(stasis),
1, 2, 10, 50, 100, and 200 s
1. The increase in EA was determined with the integrated back-
scatter coefﬁcient as a function of time and shear rate.
RESULTS — The time required to form aggregates was shorter in diabetic patients at shear
rates below 200 s
1 (P  0.01). Erythrocytes formed larger aggregates in diabetic patients than
in control subjects (P  0.05 at 2 to 100 s
1).
CONCLUSIONS — Ultrasound can potentially noninvasively demonstrate, in vivo and in
situ, the impact of local abnormal EA on arteriovenous ﬂow disorders in diabetes.
Diabetes Care 31:1400–1402, 2008
F
low disorders in diabetes often lead
tosevereoutcomesinvariousorgans
and tissues; abnormal rheology of
erythrocytes (RBC) likely impairs macro-
and microcirculatory blood ﬂow, tissue
oxygenation,andvasculartoneregulation
in affected patients (1–3). Diabetic reti-
nopathy is attributed to microvascular
ﬂow disorders and enhanced RBC aggre-
gation (4). Erythrocyte aggregation (EA)
andplasmaviscosityarealsopredictiveof
diabetic foot syndrome deterioration (5).
EA is a reversible phenomenon responsi-
ble for increased blood viscosity at low
shear rates. RBC hyperaggregation can
also promote ﬂow stasis and thrombosis
in macrocirculation. This study proposes
an ultrasound method that has the poten-
tialtononinvasivelydetectearlyrheologi-
cal disorders in situ in blood vessels. The
method is based on backscattering of ul-
trasound by blood; it measures the extent
of EA and its shear rate dependency.
RESEARCH DESIGN AND
METHODS
Populations
Recruited individuals were nonsmoking
males. They completed a questionnaire
on current medications and medical his-
tory. BMI and blood pressure were mea-
sured. Nine patients with type 2 diabetes
and eight healthy control subjects gave
informed consent to the approved proto-
col. Patients with poor metabolic control
were intentionally chosen. Lipid proﬁle
and inﬂammatory proteins (ﬁbrinogen,
Von Clauss method; haptoglobin and im-
munoglobin G, immunonephelometric
method; and C-reactive protein, latex ag-
glutination technique) were determined
for each participant.
Six patients were on oral antidiabetic
and aspirin medications, three were on
insulin, ﬁve were on cholesterol-lowering
therapy, and four were treated for hyper-
tension. Those on insulin had a history of
coronary artery disease, and two of them
had suffered from myocardial infarction.
Distal angiopathy or cutaneous trophic
disorders were not present. Mean  SD
age of patients was 58.3  8.8 years
(range 41–70). Healthy subjects were age
matched (51.1  8.7 years [range 41–
64]), did not take regular medications,
and had no history of cardiovascular dis-
ease. None had lipid disorders or hyper-
tension.
Couette experiments
A Couette instrument made of two con-
centric cylinders and installed in an incu-
bator at 37°C generated homogeneous
shear rates via a rotating outer cylinder.
Fifty milliliters of EDTA anticoagulated
blood at 40% hematocrit was introduced
between both cylinders. The stationary
inner cylinder held an ultrasound trans-
ducerperpendiculartoﬂow.The32-MHz
polyvinylidine ﬂouride ultrasound trans-
ducer (Visualsonics, Toronto, Canada)
hada6dBbandwidthof15–45MHz.It
was pulsed with bipolar square waves
(model no. AVB2-TA-C-CRIMA; Avtech,
Ottawa, Canada). Received radio fre-
quency (RF) echoes (model no. AU-3A-
0120; Miteq, Hauppauge, NY) were
ampliﬁed by 54 dB, ﬁltered between 10
and 50 MHz (model no. 5900 PR; Pana-
metrics, Waltham, MA), and digitized at
250 MHz (model no. 8500 CS; Gage-
Scope, Montreal, Canada).
The protocol consisted of imposing a
500 s
1 shear rate for 120 s to disrupt
aggregates. Then, aggregation kinetics
were recorded for 380 s at randomly ap-
plied reduced shear rates of 0, 1, 2, 10,
50, 100, and 200 s
1. One hundred RF
echoes were acquired every 2 s. For each
blood sample, the protocol was repeated
three times for averaging. RF signals were
adjusted to compensate for blood attenu-
ation at each shear rate and integrated
backscatter coefﬁcient (IBSC) was deter-
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reﬂects the number of RBC per aggregate
(7).
RESULTS— BMI, blood pressure,
triglycerides, total cholesterol, HDL and
LDL cholesterol, ﬁbrinogen, and C-reac-
tive protein were not different between
groups (P  0.05; unpaired t tests),
whereas immunoglobin G (8.4  1.0 vs.
11.3  1.8 g/l, P  0.001), haptoglobin
(1.0  0.4 vs. 1.6  0.5 g/l, P  0.05),
and A1C (5.5  0.8 vs. 8.8  2.1%, P 
0.01)weresigniﬁcantlyhigherindiabetic
patients than in control subjects. Couette
ﬂow protocol resulted in disaggregation
of RBC and minimum IBSC at 500 s
1,
formation of aggregates and rapid in-
crease in IBSC depending on reduced
applied shear (Fig. 2 of ref. 7), and devel-
opment of stable aggregate sizes and pla-
teaus of IBSC after a few seconds for most
shears to minutes at 0 s
1.
Figure 1A summarizes mean raising
slopes of IBSC between 2 and 8 s after
shear rate reductions. In control subjects,
maximumslopeat2s
1wasnotdifferent
from that at 1 and 10 s
1 (P  0.89),
whereas in diabetic patients, maximum
slope of IBSC occurring at 2 s
1 was sim-
ilar to that at 1 s
1 (P  1.0). Except for
that at 200 s
1 (P  0.11), kinetic slopes
were always faster in diabetic patients,
which is indicative of higher rates of
neighboring RBC clustering.
IBSC at plateaus averaged between
180 and 380 s after shear rate reductions
as presented in Fig. 1B. In control sub-
jects, maximum IBSC at 2 s
1 was similar
to those at 0 and 1 s
1 (P  0.95). Simi-
larly, IBSCs at 1 and 2 s
1 were similar in
diabetic patients (P  0.95). IBSCs were
statistically higher in diabetic patients be-
tween 2 and 100 s
1, which reﬂects
stronger adhesions and bigger steady-
state aggregate sizes in diabetes.
CONCLUSIONS — Statistically sig-
niﬁcant differences in Fig. 1 were noted
for shears between 2 and 100 s
1, which
correspond to normal ﬂow at center
streams and pathological ﬂow stasis in re-
circulation zones of large systemic veins
and arteries. Accordingly, EA in diabetes
can be related to lower-limb artery isch-
emic events, microangiopathy in foot ex-
tremities, and retinopathy. Inﬂammation
is involved in pathogenesis of type 2 dia-
betes and RBC aggregation, which agrees
with our results (legend of Fig. 1). Sub-
acute inﬂammatory state promoting RBC
aggregationisalsoassociatedwithobesity
(8) and metabolic syndrome (9). Thus,
reducing inﬂammation (and indirectly
aggregation) with statins and A1C with
antidiabetic medication and/or diet are in-
dicated because both have known beneﬁts
tocardiovascularconsequencesofdiabetes.
We reported measurements from a labora-
tory instrument, but a short-term objective
is sizing RBC aggregates in vivo with ultra-
sound (10). At 32 MHz, superﬁcial (5–6
mm depth) vessels can be scanned. The
proposed noninvasive method should be
Figure 1—A: Raising slopes from 2 to8so ft h eIBSC as a function of the shear rate applied to
bloodsamples(meansSD).B:IBSCattheplateauofRBCaggregationasafunctionoftheshear
rate. The power of 0 dB corresponds to that of a perfect ﬂat stainless steel reﬂector. Two-way
analyses of variance (Tukey method for multiple comparisons) conﬁrmed impact of shear rate
(P0.001)andpopulation(P0.001)onIBSCslopesandIBSCatplateaus.ThePvaluesshown
on the ﬁgure correspond to multiple comparisons between populations. IBSC slopes at 2 s
1 were
correlatedwithphysiologicalvariables(Pearsoncoefﬁcientr0.59,P0.02forA1C;r0.53,
P  0.03 for ﬁbrinogen; r  0.54, P  0.02 for immunoglobin G; and r  0.72, P  0.001 for
haptoglobin). Forward-stepwise regressions explained IBSC kinetic slopes at 2 s
1 by the follow-
ingmodel(r0.94):IBSCkinetic1.00(P0.009)0.67haptoglobin(P0.001)0.11
immunoglobin G (P  0.003)  5.60 A1C (P  0.048). Only immunoglobin G was positively
correlated with the plateau of IBSC at 2 s
1 (Pearson coefﬁcient r  0.49, P  0.046).
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tential beneﬁt for diagnosis and follow-up
of diabetic foot complications and for mon-
itoring therapy.
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